Rapid Research in Diagnostics Development for TB Network (R2D2TB Network)
Tuberculosis
About this trial
This is an interventional diagnostic trial for Tuberculosis focused on measuring Tuberculosis, Diagnostics, Global Health
Eligibility Criteria
Inclusion Criteria:
- For evaluation of TB triage/diagnostic test: We will include adult outpatients (age ≥18 years) with either a cough ≥2 weeks' duration or a known TB risk factor (HIV or diabetes).
- For evaluation of rDST tests: We will include adults (age ≥18 years) who are positive for TB and RIF resistance according to routine diagnostic testing (based typically on Xpert MTB/RIF, Xpert MTB/RIF Ultra, or Hain MTBDRplus).
- For the usability assessment: We will include health workers at each clinical site who are 1) aged ≥18 years and 2) involved in routine TB testing (collecting specimens for or performing TB tests).
Exclusion Criteria:
- For evaluation of TB triage/diagnostic tests: We will exclude patients who: completed latent or active TB treatment within the past 12 months (to increase TB prevalence and reduce false-positive results, respectively); have taken any medication with anti-mycobacterial activity (including fluoroquinolones) for any reason, within 2 weeks of study entry (to reduce false-negatives); reside >20km from the study site or are unwilling to return for follow-up visits; or are unwilling to provide informed consent
- For evaluation of rDST tests: We will exclude patients who: have negative or contaminated results on all baseline (i.e., enrollment) sputum cultures; are unable to provide at least two sputum specimens of 3 mL each within one day of enrollment; or are unable or unwilling to provide informed consent.
- For the usability assessment: We will exclude staff who are unwilling to provide informed consent.
Sites / Locations
- National Center for Tuberculosis and Lung DiseasesRecruiting
- Chitoor (Christian Medical College satellite campus)Recruiting
- Christian Medical College CMC Pulmonary Outpatient DepartmentRecruiting
- Primary care clinics (Shalom/LCC, CHAD)Recruiting
- De La Salle Medical and Health Sciences InstituteRecruiting
- Brooklyn Chest HospitalRecruiting
- Khayelitsha District Health CenterRecruiting
- Kraaifontein Community Health ClinicRecruiting
- Scottsdene primary care clinicRecruiting
- Wallacedene primary care clinicRecruiting
- Kisenyi Health CenterRecruiting
- Mulago Outpatient DepartmentRecruiting
- Hanoi Lung Hospital, Outpatient departmentsRecruiting
- National Lung Hospital, Outpatient departmentsRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Evaluation of various novel TB triage and diagnostic tests.
Evaluation of novel rDST assays
For the novel TB triage and diagnostic tests, the investigators will conduct large-scale evaluation of design-locked tests in a cohort of adults with presumed TB, with nested feasibility/pilot studies of early and late prototype tests. The investigators aim to enroll 300-450 participants per year at each of five enrollment sites for evaluation of various novel TB triage and diagnostic tests and 50 health workers to assess test usability.
Clinicians at participating sites will be asked to refer adult patients with rifampin-resistance identified by routine molecular testing. The investigators aim to enroll 100-200 patients per year at each of three enrollment sites for evaluation of novel rDST assays.